National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 01:58:22
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0264-3105-11 | EA - Each | 0264-3105 | 69646f90-f790-40d4-bedc-0ea5b335d8f0 | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0264-3105 | 0264-3105-11 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050779-001 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | ||
| N050779-002 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | |
| N050779-003 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | |
| N050779-004 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 5bbf6a4d5a75… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | N050779-001 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-002 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-003 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-001 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-002 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-003 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-001 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-002 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-003 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-001 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-002 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-003 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-001 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-002 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-003 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-001 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-002 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-003 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-001 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-002 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-003 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-001 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-002 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-003 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-001 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-002 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-003 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-001 | NPP | 2023-11-23 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-002 | NPP | 2023-11-23 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-003 | NPP | 2023-11-23 | e64feba35796… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefazolin Sodium | CEFAZOLIN SODIUM | B. Braun Medical Inc. | 17f8f038-c204-4dab-80d7-6f7ac41ddbec | 2025-03-10 | Warnings, Adverse reactions | 0264-3105-11 00264310511 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.